Suraksha Diagnostic reported a strong Q1 FY27 with consolidated revenue up 20.7% to ₹87.65 crore and profit rising 39.9% to ₹12.85 crore. The company also appointed a new CFO and set a dividend record date.
Suraksha Diagnostic Reports Strong Q1 FY27 Earnings, Appoints New CFO
Consolidated Revenue: ₹87.65 crore Consolidated Profit: ₹12.85 crore Reader Takeaway: Strong revenue and profit growth offset by ongoing subsidiary dispute. ## What just happened Suraksha Diagnostic Ltd. announced its consolidated financial results for the first quarter ended June 30, 2026. The company reported a revenue of ₹87.65 crore, a significant increase from ₹72.59 crore in the same quarter last year. Consolidated profit for the period also saw a substantial rise, reaching ₹12.85 crore, up from ₹9.18 crore in Q1 FY26. ## Why this matters The strong year-on-year growth in both revenue and profit indicates a healthy performance in the company's core diagnostic operations. The appointment of Mr. Dinesh Gupta as the new CFO, effective August 24, 2026, signals a strengthening of the finance leadership. Additionally, the company has set September 15, 2026, as the record date for its dividend payout for the financial year ended March 31, 2026. ## The backstory This quarter's performance is viewed against a backdrop of an ongoing dispute with the Government of Meghalaya concerning a step-down subsidiary. This dispute has led to operational losses and required the company to provide ₹0.81 crore against potential recovery of investments and receivables totaling ₹3.94 crore. ## What changes now The company is focused on its financial growth while managing the challenges posed by the Meghalaya subsidiary dispute. The new CFO's appointment will likely bring fresh perspectives to financial management and strategy. Shareholders will be looking forward to the dividend payout and the outcomes of the Annual General Meeting scheduled for September 22, 2026. ## Risks to watch The primary risk remains the arbitration proceedings with the Government of Meghalaya. While the company has made a provision, the final outcome could impact subsidiary performance and overall consolidated earnings. Any further escalation or prolonged legal battle could create operational and financial strain. ## Peer comparison (No specific peer data available in the filing.) ## Context metrics (time-bound) The company provided ₹0.81 crore provision against ₹3.94 crore receivables related to the Meghalaya subsidiary dispute. ## What to track next Investors should monitor future financial disclosures for updates on the Meghalaya dispute resolution. The company's ability to grow its core business while mitigating the impact of the subsidiary issue will be crucial. Performance post-new CFO's joining and AGM outcomes are also key events.
